Selected publications
-
Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.
Journal of Thoracic Oncology.
2008
Academic Article
GET IT
Times cited: 7 -
Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer.
Journal of Thoracic Oncology.
2006
Academic Article
GET IT
Times cited: 21 -
A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancer.
Lung Cancer.
2003
Academic Article
GET IT
Times cited: 31 -
Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: A phase I study.
Lung Cancer.
2002
Academic Article
GET IT
Times cited: 18 -
Phase I study of dose-dense alternating doublets in advanced non-small-cell lung cancer.
Clinical Lung Cancer.
2002
Academic Article
GET IT
Times cited: 2 -
A phase I trial of the oral platinum analogue JM216 with concomitant radiotherapy in advanced malignancies of the chest.
Investigational New Drugs.
2001
Academic Article
GET IT
Times cited: 16 -
A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer.
Investigational New Drugs.
2001
Academic Article
GET IT
Times cited: 20